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Development of novel chemotherapeutic agents aims to obtain more effective and selective 
compounds. Platinum(II)-containing chemotherapeutics have been widely used for decades in 
cancer therapy against solid tumors due to their effectiveness; although, their use is 
accompanied by drawbacks such the serious side-effects and resistance [1]. To overcome these 
problems, efforts have been made to find better alternatives such as the complexes of other 
platinum metals. 8-hydroxyquinolines and their metal complexes are widely investigated due 
to their anticancer properties [2,3]; however, they often have limited water solubility. In this 
work two novel water-soluble 8-hydroxyquinoline-D-amino acid hybrids, [(R)-1-((5-chloro-8-
hydroxyquinolin-7-yl)methyl)pyrrolidine-2-carboxylic acid (8HQCl-D-Pro) and its homologue 
8HQCl-D-hPro (Chart 1), and their [Ru(η6-p-cymene)(H2O)3]
2+ and [Rh(η5-C5Me5)(H2O)3]
2+ 




Chart 1. Chemical structure of the ligands and the organometallic triaqua cations and ORTEP 
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An 8-hydroxyquinoline-L-proline hybrid and its half-sandwich complexes have already been 
investigated in our group [4]; herein, we aimed to investigate (i) the impact of changing the 
structure (proline vs. homoproline) and chirality (L vs. D) of the ligand on the anticancer 
activity, (ii) solution chemical properties, (iii) complex formation with [Ru(η6-p-
cymene)(H2O)3]
2+ and [Rh(η5-C5Me5)(H2O)3]
2+ (Chart 1) as well as (iv) the interactions with 
biomolecules such as human serum albumin (HSA) and calf-thymus DNA (ct-DNA). 
The coupling of 5-chloro-8-hydroxyquinoline with D-proline or D-homoproline was 
achieved via a modified Mannich reaction in methanol under reflux conditions. The ligands and 
the metal complexes were synthesized similarly as the analogous 8HQCl-L-Pro and its 
complexes in our previous work [4]. 
Proton dissociation processes of the ligands and complex formation equilibria were 
characterized using pH-potentiometry, UV-visible spectrophotometry and 1H NMR 
spectroscopy in pure water in the absence of chloride ions. Based on the pKa values determined 
for 8HQCl-D-Pro and 8HQCl-D-hPro, it was concluded that these ligands are neutral at 
physiological pH; however, due to their zwitter-ionic structure at the proline moiety they 
possess excellent water-solubility. The complex formation process was much slower with 
[Ru(η6-p-cymene)(H2O)3]
2+ in comparison to [Rh(η5-C5Me5)(H2O)3]
2+, and all the metal 
complexes were characterized by high solution stability in the whole pH range studied. The 
ligand coordinates via (N,O) donor atoms to the metal centers, which was confirmed by the X-
ray crystallographic analysis of the complex [Rh(5-C5Me5)(8HQCl-D-hPro)Cl] (Chart 1). The 
proton dissociation of the coordinated water and the non-coordinated proline-NH+ of the bound 
ligand was characterized by such high pKa values that their deprotonation does not take place 
at pH 7.4. The logK’ values determined for the H2O/Cl
‒ exchange process were significantly 
higher in case of the Rh(η5-C5Me5)-complexes representing their stronger chloride ion affinity. 
Lipophilicity of the homoproline derivative 8HQCl-D-hPro was higher than 8HQCl-D-Pro, and 
the same trend was observed for the metal complexes as well. The higher chloride ion 
concentration of the medium increases the lipophilicity of the complexes due to the higher 
fraction of the neutral chlorido complex. 
Interaction of the organometallic complexes of 8HQCl-D-Pro and 8HQCl-D-hPro with 
HSA and ct-DNA was investigated using of UV-visible spectrophotometry, 
spectrofluorometry, 1H NMR spectroscopy and capillary zone electrophoresis (CZE), and 
results were compared to those of the analogous 8HQCl-L-Pro compounds. Formation of the 
complex-HSA adducts was much slower for Ru(η6-p-cymene) complexes. No ligand release 
was found upon the protein binding. Our studies suggest the coordination nature of the binding, 
most likely a histidine nitrogen donor atom of the protein coordinates to the metal center. This 
suggestion was supported based on the results obtained with histidine-containing model 
oligopeptides. The complexes have similar and strong affinity towards HSA according to the 
fluorometric and CZE measurements. They also interact with ct-DNA however, significant 
differences were found between the complexes of the D-proline and the L-proline derivatives. 
Cytotoxicity of the ligands as well as their complexes was measured in vitro against 
human cancer cells and normal cells. Both ligands showed significant cytotoxicity in Colo 205 
and Colo 320 adenocarcinoma cells (IC50 = 12 – 17 µM). The Rh(η
5-C5Me5)-complexes display 
similar or a somewhat lower toxicity (IC50 = 19 – 34 µM) than the ligands; however they were 
more selective against the cancer cells. The Ru(η6-p-cymene) complexes were ineffective 
against both cancer cell lines, possibly due to the loss of the arene ring.  
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